Patients’ characteristics at cART initiation (N = 1572).

cART, combination antiretroviral therapy; HBV, hepatitis B virus; HCV, hepatitis C virus; PMTCT, prevent of mother-to-child transmission; ADE, AIDS-defining event; NNRTI, non-nucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; PI, protease inhibitor; IQR, inter-quartile range.aPercentage based on total with data available. Number with missing data: sex (1), HCV status (269), CD4 count (32), HIV-1 RNA (137), haemoglobin (59).bADEs were defined as either mild or moderate/severe based on prognostic categories proposed by Mocroft et al [26]. Note only 2 patients were previously diagnosed with a severe ADE.cThe 46 patients starting with regimens containing NNRTI+PI were all previously on dual therapy.